Copyright
©The Author(s) 2024.
World J Clin Cases. Jul 26, 2024; 12(21): 4601-4608
Published online Jul 26, 2024. doi: 10.12998/wjcc.v12.i21.4601
Published online Jul 26, 2024. doi: 10.12998/wjcc.v12.i21.4601
Table 5 Relief of dysmenorrhea degree and drug side effects of dienogest, n (%)
| Medication for 6 months | Medication for 12 months | |
| Number of weight gain (n = 81) | 33/81 (40.7) | 28/81 (34.6) |
| Number of patients with remission of dysmenorrhea (n = 64) | 63/64 (98.4) | 64/64 (100) |
| Number of amenorrhea patients (n = 81) | 49/81 (56.3) | 56/81 (69.1) |
| Number of irregular vaginal bleeding (n = 81) | 10/81 (12.3) | 7/81 (8.6) |
| Number of patients with acne (n = 81) | 3/81 (3.7) | 2/81 (2.5) |
| Number of patients with breast tenderness (n = 81) | 8/81 (9.9) | 11/81 (13.6) |
| Number of patients with headache (n = 81) | 4/81 (4.9) | 5/81 (6.2) |
| Number of patients suffering from depression (n = 81) | 14/81 (17.3) | 16/81 (19.8) |
| Number of patients with decreased sexual desire (n = 81) | 1/81 (1.2) | 1/81 (1.2) |
| Number of patients with hair loss (n = 81) | 9/81 (11.1) | 9/81 (11.1) |
| Average drug tolerance score (n = 81) | 9.30 ± 2.14 | 8.73 ± 2.51 |
- Citation: Zhang DY, Huang Y, Peng C, Zhou YF. Effect of dienogest treatment on uterine fibroid volume in patients with endometriosis or adenomyosis complicated by uterine fibroids. World J Clin Cases 2024; 12(21): 4601-4608
- URL: https://www.wjgnet.com/2307-8960/full/v12/i21/4601.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i21.4601